NDC 0002-6145 Baqsimi
Glucagon Powder Nasal - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 0002 - Eli Lilly And Company
- 0002-6145 - Baqsimi
Product Packages
NDC Code 0002-6145-11
Package Description: 1 TUBE in 1 CARTON / 1 BOTTLE, UNIT-DOSE in 1 TUBE (0002-6145-02) / 1 POWDER in 1 BOTTLE, UNIT-DOSE (0002-6145-01)
Price per Unit: $269.07429 per EA
NDC Code 0002-6145-27
Package Description: 2 TUBE in 1 CARTON / 1 BOTTLE, UNIT-DOSE in 1 TUBE (0002-6145-02) / 1 POWDER in 1 BOTTLE, UNIT-DOSE (0002-6145-01)
Price per Unit: $269.06615 per EA
Product Details
What is NDC 0002-6145?
What are the uses for Baqsimi?
What are Baqsimi Active Ingredients?
- GLUCAGON 3 mg/1 - A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511)
Which are Baqsimi UNII Codes?
The UNII codes for the active ingredients in this product are:
- GLUCAGON (UNII: 76LA80IG2G)
- GLUCAGON (UNII: 76LA80IG2G) (Active Moiety)
Which are Baqsimi Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BETADEX (UNII: JV039JZZ3A)
- WATER (UNII: 059QF0KO0R)
- ACETIC ACID (UNII: Q40Q9N063P)
What is the NDC to RxNorm Crosswalk for Baqsimi?
- RxCUI: 2180666 - glucagon 3 MG Nasal Powder
- RxCUI: 2180671 - baqsimi 3 MG Nasal Powder
- RxCUI: 2180671 - glucagon 3 MG Nasal Powder [Baqsimi]
- RxCUI: 2180671 - Baqsimi 3 MG Nasal Powder
Which are the Pharmacologic Classes for Baqsimi?
- Antihypoglycemic Agent - [EPC] (Established Pharmacologic Class)
- Decreased GI Motility - [PE] (Physiologic Effect)
- Decreased GI Smooth Muscle Tone - [PE] (Physiologic Effect)
- Decreased Glycolysis - [PE] (Physiologic Effect)
- Gastrointestinal Motility Inhibitor - [EPC] (Established Pharmacologic Class)
- Increased Gluconeogenesis - [PE] (Physiologic Effect)
- Increased Glycogenolysis - [PE] (Physiologic Effect)
* Please review the disclaimer below.
Patient Education
Glucagon Nasal Powder
Glucagon nasal powder is used along with emergency medical treatment to treat very low blood sugar in adults and children 4 years of age and older who have diabetes. Glucagon nasal powder is in a class of medications called glycogenolytic agents. It works by causing the liver to release stored sugar to the blood.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".